UBS Group
TEAR

UBS Group’s TearLab Corporation TEAR Stock Holding History

UBS Group’s Portfolio TEAR Stock Details TEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-200
Closed – – 8451
2017
Q3 		$0 Sell
200
-4,120
-95% -$7.29K ﹤0.01% 8372
2017
Q2 		$7K Buy
4,320
+1,407
+48% +$2.86K ﹤0.01% 7017
2017
Q1 		$8K Buy
+2,913
New +$14.4K ﹤0.01% 6788
2016
Q4 		– Sell
-671
Closed -$4K – 8338
2016
Q3 		$4K Sell
671
-43
-6% -$320 ﹤0.01% 7243
2016
Q2 		$5K Sell
714
-649
-48% -$4.75K ﹤0.01% 7183
2016
Q1 		$9K Buy
1,363
+629
+86% +$6.25K ﹤0.01% 6754
2015
Q4 		$10K Buy
734
+484
+194% +$8.3K ﹤0.01% 7317
2015
Q3 		$5K Hold
250
– – ﹤0.01% 7767
2015
Q2 		$5K Hold
250
– – ﹤0.01% 7914
2015
Q1 		$5K Sell
250
-326
-57% -$7.83K ﹤0.01% 8160
2014
Q4 		$16K Buy
+576
New +$15.9K ﹤0.01% 7988

Other funds holding TEAR

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
JPMIA
J.P. Marvel Investment Advisors Boston, Massachusetts $705M AUM 43.01% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return

UBS Group's TEAR Position: Q4 2017 in Review

UBS Group sold out of TearLab Corporation (TEAR) in Q4 2017, closing a stake of 200 shares.

UBS Group first reported a position in TEAR in Q4 2014 and held it in 11 quarters. The position peaked at $16K in Q4 2014. 3 funds tracked by Wall St. Rank hold TEAR as of Q4 2017.

  • UBS Group reported no remaining TearLab Corporation position as of Q4 2017 after selling out during the quarter.
  • UBS Group sold 200 TearLab Corporation shares in Q4 2017.
  • UBS Group first reported a position in TearLab Corporation in Q4 2014 and held it in 11 quarters.
  • UBS Group's TearLab Corporation position peaked at $16K in Q4 2014.
  • 3 funds tracked by Wall St. Rank held TearLab Corporation as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.